SAN ANTONIO — Zealand Pharma, hoping to create the next "foundational" therapy for obesity, detailed more Phase 1 data on its amylin analog that was the backbone of a $1 billion raise ...
READ MOREValneva is eyeing a 2027 launch for its Pfizer-partnered Lyme disease vaccine, CEO Thomas Lingelbach said Thursday during the company’s investor day.
READ MOREAstraZeneca's Alexion, BridgeBio, BioMarin, Ultragenyx and others, including Sen. Bob Casey (D-PA), recently weighed in on the details of a new cross-cutting FDA collaboration hub focused ...
READ MORECatalent reported a slight revenue upswing during its latest quarterly results, which CEO Alessandro Maselli attributed to "customers' continued confidence” in the CDMO. Yet the ...
READ MORE